Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,739 | 320 | 91.1% |
| Travel and Lodging | $463.85 | 1 | 6.3% |
| Education | $197.08 | 17 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $734.84 | 36 | $0 (2024) |
| Philips Electronics North America Corporation | $727.11 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $516.49 | 30 | $0 (2024) |
| Abbott Laboratories | $488.81 | 15 | $0 (2024) |
| Cardiovascular Systems Inc. | $474.74 | 17 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $382.70 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $354.05 | 19 | $0 (2023) |
| ABIOMED | $343.78 | 8 | $0 (2024) |
| Amgen Inc. | $315.41 | 15 | $0 (2024) |
| Novo Nordisk Inc | $251.79 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,564 | 67 | Philips North America LLC ($190.11) |
| 2023 | $1,259 | 52 | Philips Electronics North America Corporation ($135.01) |
| 2022 | $576.68 | 23 | Philips Electronics North America Corporation ($128.25) |
| 2021 | $130.30 | 8 | ABIOMED ($50.89) |
| 2020 | $390.44 | 14 | Abbott Laboratories ($232.43) |
| 2019 | $1,046 | 62 | Cardiovascular Systems Inc. ($224.23) |
| 2018 | $1,564 | 72 | Philips Electronics North America Corporation ($463.85) |
| 2017 | $870.29 | 40 | AstraZeneca Pharmaceuticals LP ($166.08) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.62 | General |
| Category: Cardiovascular | ||||||
| 12/17/2024 | Philips North America LLC | (5050) Ext Holter (Device) | Food and Beverage | Cash or cash equivalent | $50.08 | General |
| Category: Medical Device | ||||||
| 12/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $45.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $26.81 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $41.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $30.92 | General |
| Category: Coronary | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Renal Denervation System | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2024 | Philips North America LLC | (BR3) Coronary Other (Device) | Food and Beverage | Cash or cash equivalent | $36.70 | General |
| Category: Medical Device | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardiology | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/19/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/14/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Transcatheter Heart Valves | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,734 | 3,972 | $722,212 | $235,929 |
| 2022 | 27 | 2,718 | 3,971 | $702,699 | $232,151 |
| 2021 | 30 | 3,079 | 4,391 | $800,065 | $263,017 |
| 2020 | 30 | 3,016 | 4,082 | $661,827 | $198,415 |
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 568 | 918 | $229,362 | $88,228 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 153 | 202 | $67,933 | $28,463 | 41.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 270 | 289 | $61,846 | $16,475 | 26.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 31 | 36 | $54,315 | $14,983 | 27.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 58 | 61 | $47,153 | $10,931 | 23.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 112 | $27,731 | $10,863 | 39.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 76 | 87 | $21,737 | $7,960 | 36.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 56 | $26,626 | $7,381 | 27.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 659 | 941 | $20,702 | $6,170 | 29.8% |
| 92941 | Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | Facility | 2023 | 14 | 14 | $27,635 | $5,964 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $15,668 | $5,493 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 84 | $14,018 | $5,160 | 36.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 71 | $12,255 | $4,736 | 38.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $11,038 | $3,926 | 35.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $13,040 | $3,137 | 24.1% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $9,581 | $2,380 | 24.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 150 | 175 | $8,887 | $2,044 | 23.0% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 31 | 31 | $3,944 | $1,801 | 45.7% |
| 85610 | Blood test, clotting time | Office | 2023 | 36 | 409 | $8,589 | $1,718 | 20.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 120 | 123 | $4,935 | $1,418 | 28.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 20 | $3,338 | $1,377 | 41.3% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 17 | 17 | $5,066 | $1,289 | 25.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 100 | 105 | $14,595 | $1,074 | 7.4% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 16 | 16 | $3,808 | $928.32 | 24.4% |
| 93572 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | Facility | 2023 | 13 | 15 | $1,683 | $630.02 | 37.4% |
About Dr. Richard Gerber, M.D
Dr. Richard Gerber, M.D is a Interventional Cardiology healthcare provider based in Salinas, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407854599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Gerber, M.D has received a total of $7,400 in payments from pharmaceutical and medical device companies, with $1,564 received in 2024. These payments were reported across 338 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($6,739).
As a Medicare-enrolled provider, Gerber has provided services to 11,547 Medicare beneficiaries, totaling 16,416 services with total Medicare billing of $929,512. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Location Salinas, CA
- Active Since 07/12/2005
- Last Updated 11/07/2013
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1407854599
Products in Payments
- BRILINTA (Drug) $521.17
- IVUS Systems (Device) $463.85
- Coronary Orbital Atherectomy System (Device) $432.55
- XARELTO (Drug) $354.05
- Impella (Device) $343.78
- ELIQUIS (Drug) $308.12
- ENTRESTO (Drug) $290.68
- LEQVIO (Drug) $225.81
- Repatha (Biological) $223.08
- Ozempic (Drug) $193.32
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $162.96
- (5050) Ext Holter (Device) $153.41
- (6571) Eagle Eye (Device) $135.01
- FARXIGA (Drug) $130.11
- NORTHERA (Drug) $126.56
- CAMZYOS (Drug) $119.42
- Arcalyst (Drug) $110.71
- JARDIANCE (Drug) $106.24
- MULTAQ (Drug) $104.47
- LifeVest (Device) $98.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Salinas
Mr. Rikin Kadakia, M.d, M.D
Interventional Cardiology — Payments: $122,953
Dr. Thomas Mustoe, M.d, M.D
Interventional Cardiology — Payments: $21,428
Dr. Patrik Zetterlund, M.d, M.D
Interventional Cardiology — Payments: $17,845